Developing new antibodies to prevent HIV infection
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
This study is looking at new types of antibodies that can help fight HIV by targeting different parts of the virus, with the goal of making treatments last longer and be easier to stick with, and people living with HIV might have a chance to join clinical trials to test these exciting new options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-10811567 on NIH RePORTER |
What this research studies
This research focuses on creating broadly neutralizing antibodies (bnAbs) that can effectively target and neutralize the HIV virus. The approach involves evaluating multiple bnAbs that recognize different parts of the HIV envelope protein, which may enhance their effectiveness in both treatment and prevention. The study aims to improve the longevity of these antibodies in the body, addressing adherence issues often faced with current HIV treatments and preventive measures. Patients may have the opportunity to participate in clinical trials assessing these innovative therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk for HIV infection or those currently living with HIV who may benefit from new treatment options.
Not a fit: Patients who are not at risk for HIV or those who are already effectively managing their HIV with current treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies against HIV, potentially reducing the incidence of new infections.
How similar studies have performed: Previous research has shown promise in using broadly neutralizing antibodies for HIV treatment and prevention, indicating a potential for success with this approach.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.